These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33556539)

  • 1. Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease.
    Basak JM; Ferreiro A; Cohen LS; Sheehan PW; Nadarajah CJ; Kanan MF; Sukhum KV; Dantas G; Musiek ES
    Neurobiol Dis; 2021 May; 152():105292. PubMed ID: 33556539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis exacerbates Alzheimer's disease pathophysiology, modulates the gut microbiome, increases neuroinflammation and amyloid burden.
    Giridharan VV; Catumbela CSG; Catalão CHR; Lee J; Ganesh BP; Petronilho F; Dal-Pizzol F; Morales R; Barichello T
    Mol Psychiatry; 2023 Oct; 28(10):4463-4473. PubMed ID: 37452088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MTK; Vickers JC
    J Neurotrauma; 2019 Jun; 36(11):1876-1889. PubMed ID: 30623730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
    J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.
    Unger MS; Marschallinger J; Kaindl J; Höfling C; Rossner S; Heneka MT; Van der Linden A; Aigner L
    Mol Neurobiol; 2016 Oct; 53(8):5796-806. PubMed ID: 27544234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology progression.
    Pizzirusso G; Preka E; Goikolea J; Aguilar-Ruiz C; Rodriguez-Rodriguez P; Vazquez-Cabrera G; Laterza S; Latorre-Leal M; Eroli F; Blomgren K; Maioli S; Nilsson P; Fragkopoulou A; Fisahn A; Arroyo-García LE
    Brain Behav Immun; 2024 Jul; 119():286-300. PubMed ID: 38608739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.
    Chintapaludi SR; Uyar A; Jackson HM; Acklin CJ; Wang X; Sasner M; Carter GW; Howell GR
    J Alzheimers Dis; 2020; 73(4):1421-1434. PubMed ID: 31929156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
    Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
    Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease.
    Löffler T; Flunkert S; Havas D; Schweinzer C; Uger M; Windisch M; Steyrer E; Hutter-Paier B
    J Neuroinflammation; 2014 May; 11():84. PubMed ID: 24886182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated platelet depletion augments Alzheimer's disease neuropathological hallmarks in APP-PS1 mice.
    de Sousa DMB; Benedetti A; Altendorfer B; Mrowetz H; Unger MS; Schallmoser K; Aigner L; Kniewallner KM
    Aging (Albany NY); 2023 Feb; 15(3):630-649. PubMed ID: 36734880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease.
    Go J; Chang DH; Ryu YK; Park HY; Lee IB; Noh JR; Hwang DY; Kim BC; Kim KS; Lee CH
    Nutr Res; 2021 Feb; 86():96-108. PubMed ID: 33551257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease.
    Rivera-Escalera F; Matousek SB; Ghosh S; Olschowka JA; O'Banion MK
    Neurobiol Dis; 2014 Sep; 69():124-33. PubMed ID: 24874542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.